British Journal of Clinical Pharmacology · 1985 · 70 citations · 11 references
PharmacyPharmaceuticsPharmacologyDosage Form DesignDrug DeliveryOral Drug DeliveryControlled Release MechanismsControlled Release Oral Dosage FormsDrug Delivery SystemsDrug DispositionDrug Release From Dosage FormsDrug Release KineticsDrug Release ModelingLong-term Storage StrategiesOral Drug Delivery FormulationsOral Drug Delivery SystemsOsmotic Release SystemsPhysiologically Based Release ModelingRelease Mechanism EvaluationRelease Profile Characterization
The essential features and mode of action of oral osmotic drug delivery systems (Oros) for metoprolol fumarate and oxprenolol succinate are described. Critical aspects in the development of systems for once-daily administration of both drugs are discussed, and methods for evaluating in vitro release characteristics are presented. In vitro testing confirmed that drug delivery corresponded closely to the theoretical release behaviour predicted from the physicochemical and membrane permeability characteristics for both oxprenolol and metoprolol systems. In vitro release rates were also shown to be unaffected by pH, in vitro test procedures, dissolution media and long-term storage at different temperatures.
11
Felix Theeuwes · Journal of Pharmaceutical Sciences · 1975 · 540 citations
Calle Bengtsson, G. Johnsson, C G Regårdh · Clinical Pharmacology & Therapeutics · 1975 · 113 citations
Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
J C Petrie, T A Jeffers, OJ Robb et al. · BMJ · 1980 · 57 citations · Full text